ARG64625

anti-HRASLS2 antibody

anti-HRASLS2 antibody for IHC-Formalin-fixed paraffin-embedded sections and Human

Cancer antibody

概述

产品描述 Goat Polyclonal antibody recognizes HRASLS2
反应物种 Hu
应用 IHC-P
特异性 This design was based on provisional sequence data.
宿主 Goat
克隆 Polyclonal
同位型 IgG
靶点名称 HRASLS2
抗原物种 Human
抗原 QELPYSLTSDNC
偶联标记 Un-conjugated
別名 HRAS-like suppressor 2; EC 3.1.1.-; PLA1/2-2; EC 2.3.1.-

应用说明

应用建议
应用 推荐稀释比
IHC-P5 - 10 µg/ml
应用说明 IHC-P: Antigen Retrieval: Microwaved tissue section in Tris/EDTA buffer (pH 9.0).
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

属性

形式 Liquid
纯化 Purified from goat serum by antigen affinity chromatography.
缓冲液 Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA.
抗菌剂 0.02% Sodium azide
稳定剂 0.5% BSA
浓度 0.5 mg/ml
存放说明 For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
注意事项 For laboratory research only, not for drug, diagnostic or other use.

生物信息

数据库连接

GeneID: 54979 Human HRASLS2

Swiss-port # Q9NWW9 Human HRAS-like suppressor 2

基因名称 HRASLS2
全名 HRAS-like suppressor 2
生物功能 Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Catalyzes N-acylation of PE using both sn-1 and sn-2 palmitoyl groups of PC as acyl donor. Also catalyzes O-acylation converting lyso-PC into PC. [UniProt]
研究领域 Cancer antibody
预测分子量 17 kDa

检测图片 (1) Click the Picture to Zoom In

  • ARG64625 anti-HRASLS2 antibody IHC-P image

    Immunohistochemistry: paraffin embedded Human Liver. (Microwaved antigen retrieval with Tris/EDTA buffer pH9) stained with ARG64625 anti-HRASLS2 antibody at 5 µg/ml dilution followed by HRP-staining.